Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mannebach

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Zeitschrift Fur Kardiologie|November 25, 1998
[Changes in life style as a causal therapeutic approach in coronary heart disease]U Gleichmann, S Gleichmann, H Mannebach, et al.
Methods of Information in Medicine|August 1, 1993
Reconstructing medical problem solving competence: MACCORDD Kraus, B Petkoff, H Mannebach, et al.
Herz|June 1, 1987
[Color Doppler echocardiography in the diagnosis of aortic dissection and aortic wall abscesses]N Bogunovic, H Philippi, H Mannebach, et al.
Clinical Cardiology|June 1, 1980
Segmental early relaxation phenomenon (SREP) versus exercise-induced hypokinesia: a correlation studyG Trieb, U Sigwart, H Mannebach, et al.
Cardiology|January 1, 1981
Hemodynamics and prognosis of patients with angina pectoris without coronary heart disease (syndrome X)U Gleichmann, H Ohlmeier, H Mannebach, et al.
Zeitschrift Fur Kardiologie|August 1, 1979
[Left ventricular early relaxation phenomenon at rest compared with ischemic hypokinesis by exercise angiography: a correlative study (author's transl)]G Trieb, U Sigwart, H Mannebach, et al.
Clinical Cardiology|January 1, 1981
Influence of heart rate on systolic time intervals: effects of atrial pacing versus dynamic exerciseH M Mertens, H Mannebach, G Trieb, et al.
Deutsche Medizinische Wochenschrift (1946)|March 25, 1988
[Bradycardia factitia]S Eckert, H M Mertens, H Mannebach, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 1, 1995
Evidence against heterozygous coagulation factor V 1691 G-->A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarctionW Prohaska, H Mannebach, M Schmidt, et al.
British Journal of Clinical Pharmacology|January 1, 1982
The influence of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on local wall motion abnormalities in patients with coronary heart diseaseU Gleichmann, D Fassbender, G Trieb, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Zeitschrift Fur Kardiologie|November 25, 1998
[Changes in life style as a causal therapeutic approach in coronary heart disease]U Gleichmann, S Gleichmann, H Mannebach, et al.
Methods of Information in Medicine|August 1, 1993
Reconstructing medical problem solving competence: MACCORDD Kraus, B Petkoff, H Mannebach, et al.
Herz|June 1, 1987
[Color Doppler echocardiography in the diagnosis of aortic dissection and aortic wall abscesses]N Bogunovic, H Philippi, H Mannebach, et al.
Clinical Cardiology|June 1, 1980
Segmental early relaxation phenomenon (SREP) versus exercise-induced hypokinesia: a correlation studyG Trieb, U Sigwart, H Mannebach, et al.
Cardiology|January 1, 1981
Hemodynamics and prognosis of patients with angina pectoris without coronary heart disease (syndrome X)U Gleichmann, H Ohlmeier, H Mannebach, et al.
Zeitschrift Fur Kardiologie|August 1, 1979
[Left ventricular early relaxation phenomenon at rest compared with ischemic hypokinesis by exercise angiography: a correlative study (author's transl)]G Trieb, U Sigwart, H Mannebach, et al.
Clinical Cardiology|January 1, 1981
Influence of heart rate on systolic time intervals: effects of atrial pacing versus dynamic exerciseH M Mertens, H Mannebach, G Trieb, et al.
Deutsche Medizinische Wochenschrift (1946)|March 25, 1988
[Bradycardia factitia]S Eckert, H M Mertens, H Mannebach, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 1, 1995
Evidence against heterozygous coagulation factor V 1691 G-->A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarctionW Prohaska, H Mannebach, M Schmidt, et al.
British Journal of Clinical Pharmacology|January 1, 1982
The influence of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on local wall motion abnormalities in patients with coronary heart diseaseU Gleichmann, D Fassbender, G Trieb, et al.
Pageof 8